Friday 13 September
Maximising the Synergy of Tumour Tissue and Liquid Biopsy Testing in Oncology Clinical Practice
Friday, 10:15 - 11:45
View the satellite invitation
The Journey of ADCs in Metastatic NSCLC: Past, Present and Future
Friday, 18:00 - 19:30
View the satellite invitation
Saturday 14 September
Evolving Patient-Centered Therapies for Metastatic NSCLC
Saturday, 13:00 - 14:30
View the satellite invitation
Saturday 14 September
Targeting Un-MET Needs in Cancer: The Emerging Role of Antibody-Drug Conjugates (ADCs)
Saturday, 18:30 - 20:00
View the satellite invitation
Sunday 15 September
Driving EGFR-Mutant NSCLC Care Forward
Sunday, 13:00 - 14:30
View the satellite invitation
Sunday 15 September
Patient Matters: Innovation in Lung Cancer
Sunday, 13:00 - 14:30
View the satellite invitation
Sunday 15 September
Innovation in Lung Cancer Treatment: Unlocking the Potential of Precision Medicine
Sunday, 13:00 - 14:30
View the satellite invitation
Sunday 15 September
Setting a New Benchmark for ALK+ aNSCLC Targeted Therapy
Sunday, 18:30 - 20:00
View the satellite invitation
Sunday 15 September
Emerging Therapies in Clinical Practice: What Are the Patient Perspectives on the Future of Lung Cancer Treatment?
Sunday, 18:30 - 20:00
View the satellite invitation
Sunday 15 September
Liquid Biopsy-Based Biomarkers for Cancer Profiling and Monitoring: Current and Future Applications
Sunday, 18:30 - 20:00
View the satellite invitation
Monday 16 September
Advance, Deliver, Challenge: ADCs and the Potential Future Of mNSCLC
Monday, 13:00 - 14:30
View the satellite invitation
Monday 16 September
Precision Oncology for BRAF Mutant Cancers
Monday, 18:30 - 20:00
View the satellite invitation
Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.